Tekeli Taşkömür, A., Erten, Özlem and Dilbaz, B. (2021) “Comparison of two drospirenone-containing oral contraceptives for their effect on the ovary, menstrual cycle, acne, and side-effect profile: 20 µg ethinylestradiol/3 mg drospirenone (24/4) versus 30 µg ethinylestradiol/3 mg drospirenone (21/7)”, Journal of Surgery and Medicine, 5(11), pp. 1099–1103. doi: 10.28982/josam.1002126.